Gray-market peptides have flooded some corners of the tech scene recently, showing up in hacker houses, start-up offices and even “peptide raves” sponsored by suppliers.
In this New York Times story, LegitScript's Director of Research, Gerard Olson, talks about the online advertising of unauthorized peptide formulations and how it is helping to fuel these gray-market drugs that are flooding Silicon Valley.